NOVAREX Co.,Ltd. (KOSDAQ:194700)

South Korea flag South Korea · Delayed Price · Currency is KRW
13,830
-410 (-2.88%)
At close: Feb 27, 2026
64.25%
Market Cap 244.82B
Revenue (ttm) 385.76B
Net Income (ttm) 36.10B
Shares Out 17.70M
EPS (ttm) 2,039.00
PE Ratio 6.78
Forward PE n/a
Dividend 200.00 (1.45%)
Ex-Dividend Date Dec 29, 2025
Volume 94,278
Average Volume 89,791
Open 14,300
Previous Close 14,240
Day's Range 13,800 - 14,300
52-Week Range 8,160 - 22,100
Beta 0.23
RSI 38.28
Earnings Date Mar 20, 2026

About NOVAREX

NOVAREX Co.,Ltd. manufactures, wholesales, and retails health and functional foods in South Korea and internationally. It offers lactic acid bacteria, omega-3, icle time, eye health, diet, boswellia, and lutein and zeaxanthin, as well as vitamin and mineral products in the form of tablets, soft and hard capsules, powder, liquid, gel, and jellies. The company was formerly known as Health Science Co., Ltd. and changed its name to NOVAREX Co.,Ltd. in November 2013. NOVAREX Co.,Ltd. was founded in 1995 and is headquartered in Cheongju-si, South Kor... [Read more]

Industry Pharmaceutical Preparations
Founded 1995
Employees 464
Stock Exchange KOSDAQ
Ticker Symbol 194700
Full Company Profile

Financial Performance

In 2024, NOVAREX's revenue was 297.73 billion, a decrease of -1.47% compared to the previous year's 302.17 billion. Earnings were 23.02 billion, an increase of 4.45%.

Financial Statements

News

There is no news available yet.